Reactive oxygen species and antioxidative barrier in asthma;Reaktywne formy tlenu i bariera antyoksydacyjna w astmie

Pneumonologia i Alergologia Polska

Volumn 75, Issue 2, 2007, Pages 158-162

  Szlagatys Sidorkiewicz, Agnieszka ^a,b   Góra Gȩbka, Magdalena ^a   Korzon, Maria ^a  

^a Klinika Pediatrii   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antioxidants; Asthma; Oxidative stress; Reactive oxygen species

Indexed keywords

EID: 34547939431     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Sias H. Strategies of antioxidant defense. Eur. J. Biochem. 1993: 2 (5): 213-219.
2. Szlagatys-Sidorkiewicz A., Korzon M., Renke J., Popadiuk S., Woźniak M. Równowaga antyoksydacyjno-prooksydacyjna u dzieci leczonych kortykosteroidami wziewnymi i długodziałaja̧cymi beta-mimetykami. Pneumonol. Alergol. Pol. 2005; 73: 176-181.
3. Barnes P.J. Reactive oxygen species and airway inflammation. Free Rad. Biol. Med. 1990; 9: 235-243.
4. Kim J.Y., Lee K.H., Lee B.K., Ro J.Y. Peroxynitrite modulates release of inflammatory mediators from guinea pig lung mast cells activated by antigen-antibody reaction. Int. Arch. Allergy Immunol. 2005: 137: 104-114.
5. Ghosh S., Janocha A.J., Aronica M.A. i wsp. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J. Immunol. 2006; 176: 5587-5597.
6. Jeulin C., Guadagnini R., Marano F. Oxidant stress stimulates Ca2+-activated chloride channels in the apical activated membrane of cultured nonciliated human nasal epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005; 289: L636-L646.
7. Triggiani M., De Marino V., Sofia M. i wsp. Characterization of platelet-activating factor acetylohydrolase in human bronchoalveolar lavage. Am. J. Crit. Respir. Care Med. 1997; 156: 94-100.
8. Schneider J.C., Card G.L., Pfau J.C., Holian A. Air pollution particulate SRM 1648 causes oxidative stress in RAW 264.7 macrophages leading to production of prostaglandin E2, a potential Th2 mediator. Inhal. Toxicol. 2005; 17: 871-877.
9. Lu Y., Wahl L.M. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J. Immunol. 2005; 175: 5423-5429.
10. Park S.K., Kim S.K., Seomun Y. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem. Biophys. Res. Commun. 2001; 284: 966-971.
11. Matyas S., Pucovsky V., Bauer V. Effects of various reactive oxygen species on the guinea pig trachea and its epithelium. Jpn. J. Pharmacol. 2002; 88: 270-278.
12. Boer J., Meurs H., Flendriq L., Koopal M., Zaagsma J. Role of nitric oxide and superoxide in allergen-induced airway hyper-reactivity after the late asthmatic reaction in guinea-pigs. Br. J. Pharmacol. 2001; 133: 1235-1242.
13. Nijkamp F.P., Henricks P.A.J. Beta-adrenoreceptors in lung inflammation. Am. Rev. Respir. Dis. 1990; 141: S145-S150.
14. Ikuta O., Sugiyama S., Rakagi K., Satake T., Ozawa T. Implication of oxygen radicals on airway hyperresponsiveness after ovalbumin challenge in guinea pigs. Am. Rev. Respir. Dis. 1992; 145: 561-565.
15. Tepper J.S., Costa D.L., Fitzgerald S., Doerfler D.L., Bromberg P.A. Role of tachykinins in ozone-induced acute lung injury in guinea-pigs. J. Appl. Physiol. 1993; 75: 404-1411.
16. Krishna M.T., Springall D., Meng Q.H. i wsp. Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am. J. Respir. Crit. Care Med. 1997; 156: 943-950.
17. Henricks P.A.J., Nijkamp F.P. Reactive oxygen species as mediators in asthma. Pulm. Pharmacol. Ther. 2001; 14: 409-421.
18. Mulier B., Rahman I., Watchom T., Donaldson K., MacNee W., Jeffrey P.K. Hydrogen peroxide-induced epithelial injury: the protective role of intracellular non protein thiols (NPSH). Eur. Respir. J. 1998; 11: 384-391.
19. Hulsmann A.R., Raagteep H.R., den Hollander J.C. wsp. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways, Am. J. Crit, Care Med. 1994; 149: 519-525.
20. Adler K.B., Holden-Stauffer W.J., Repine J.E. Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid dependent mechanism. J. Clin. Invest. 1990; 85: 75-85.
21. McQuaid K.E., Smyth E.M., Keenan A.K. Evidence for modulation of hydrogen peroxide-induced endothelial barrier dysfunction by nitric oxide in vitro. Eur. J. Pharmacol. 1996; 307: 233-241.
22. MacPherson J.C., Comhair S.A., Erzurum S.C. Eosinophils are a major source of nitric-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J. Immunol. 2001; 166: 5763-5772.
23. Marcal L.E., Rehder J., Newburger P.E., Candino-Neto A. Superoxide release and cellular glutathione peroxidase activity in leukocytes from children with persistent asthma. Br. J. Med. Biol. Res. 2004; 37: 1607-1613.
24. Nadeem A., Chhabra S.K., Masood A., Raj H.G. Increased oxidative stress and altered levels of antioxidants in asthma. J. Allergy Clin. Immunol. 2003; 111: 72-78.
25. Slbille Y., Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990; 141: 471-501.
26. Bankers-Fulbright J.L., Gleich G.J., Kephart G.M., Kita H., O'Grady S.M. Regulation of human eosinophil NADPH oxidase activity: a central role for PKCdelta. J. Cell. Physiol. 2001; 189: 306-316.
27. Weiss E.B., Bellino J.R. Leukotriene-associated toxic oxygen metabolites induce airway hyperreactivity, Chest 1986; 89: 709-716.
28. Sannohe S., Adachi T., Hamada K. Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis. Eur. Respir. J. 2003; 21: 925-931.
29. Joseph B.Z., Routes J.M., Borish L. Activities of superoxide dismutase and NADPH oxidase in neutrophils obtained from asthmatic and normal donors. Inflammation 1993; 17: 361-370.
30. Demoly P., Damon M., Michel F.B., Godard P. IFN-γ activates superoxide anion production in blood monocytes from allergic asthmatic patients. Ann. Allergy Asthma Immunol. 1995; 75: 162-166.
31. Klabunde R.E., Anderson D.E. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage, J. Vasc. Res. 2002; 39: 238-245.
32. Hattori H., Imai H., Furuhuma K., Sato O., Nagakawa Y. Induction of phospholipid hydroperoxide glutathione peroxidase in human polymorphonuclear neutrophils and HL60 cells stimulated with TNF-alpha, Biochem. Biophys. Res. Commun. 2005; 337: 464-473.
33. Nagata M., Sedgwick J.B., Vrtis R., Busse W.W. Endothelial cells upregulate superoxide generation via VCAM-I expression. Clin. Exp. Allergy 1999; 29: 550-561.
34. Rankin J.A., Harris P., Ackerman S.J. The effects of eosinophil-granule major basic protein on lung-macrophage superoxide anion generation. J. Allergy Clin. Immunol. 1992; 89: 746-752.
35. Antczak A., Nowak D., Shariati B., Król M., Piasecka G., Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur. Respir. J. 1997; 10: 1235-1241.
36. Loukides S., Bouros D., Papatheodorou G., Panagou G., Siafakas N.M. The relationship among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002;121:338-346.
37. Jobsis Q., Raagteep H.C., Hermans P.W., de Jongste J.C. Hydrogen peroxide in exhaled air is increased in stable asthmatic patients. Eur. Respir. J. 1997; 10: 519-521.
38. Yamaya M., Sekizawa K., Ishizuka S., Monama M., Sasaki H. Exhaled carbon monoxide levels during treatment of acute asthma. Eur. Respir. J. 1999; 13: 757-760.
39. Zanconato S., Scollo M., Zaramella C., Landi L., Zacchello F., Baraldi E. Exhaled carbon monoxide levels after a course of oral prednisone in children with asthma exacerbation. J. Allergy Clin. Immunol. 2002; 109: 440-445.
40. Postȩpski J., Tuszkiewicz-Misztal E., Emeryk A., Gomicka G., Wawrzyszuk M. Ocena wybranych parametrów równowagi oksydacyjno-antyoksydacyjnej u dzieci chorych na przewlekła̧ ciȩżka̧ astmȩ oskrzelowa̧. Peumonol. Alergol. Pol. 2001; 69: 553-563.
41. Vural H., Aksoy N., Ceylan E., Gencer M., Ozguner F. Leukocyte oxidant and antioxidant status in asthmatic patients. Arch. Med. Res. 2005; 36: 502-506,
42. Wood L.G., Garg M.L., Blake R.J., Garcia-Caraballo S., Gibson P.G. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000; 35: 967-974.
43. Shahid S.K., Khartionov S.A., Wilson N.M., Bush A., Barnes P.J. Exhaled 8-isoprostane in childhood asthma. Respir. Res. 2005; 6: 79.
44. Dworski R. Oxidant stress in asthma. Thorax 2000; 55 (supl. 2): S51-S53.
45. Schock B.C., Young I.S., Brown V., Fitch P.S., Shields M.D., Ennis M. Antioxidants and oxidative stress in BAL fluid of atopic asthmatic children. Pediatr. Res. 2003; 53: 375-381.
46. Sles H. Oxidative stress: From basic research to clinical application. Am. J. Med. 1991; 91 (supl. 3C): 3C-31S-3C-38S.
47. Shanmugasundaram K.R., Kumar S.S., Rajajee S. Excessive free radical generation in the blood of children suffering from asthma. Clin. Chim. Acta 2001; 305: 107-114.
48. Tho L.L., Candlish J.K. Superoxide dismutase and glutathione peroxidase acitivities in erythrocytes as indicies of oxygen loading in disease: a survey of one hundred cases. Biochem. Med. Metab. Biol. 1987; 38: 74-80.
49. De Raeve H., Thunnissen F.B., Kaneko F.T. i wsp. Decreased Cu, Zn-SOD activity in asthmatic airway epithelium correction by inhaled corticosteroid in vivo. Am. J. Physiol. 1997; 272 (1 cz. 1): L148-L154.
50. Kelly F.J., Mudway I., Blomberg A., Frew A., Sanstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354: 482-483.
51. Bentur L., Mansour Y., Brik R., Eizenberg Y., Nagler R.M. Salivary oxidative stress in children during acute asthmatic attack and during remission. Respir. Med. 2005 Nov 28 (Medline).
52. Misso N.L., Brooks-Wildhaber J., Ray S., Vally H., Thompson P.J. Plasma concentrations of dietary and nondietary antioxidants are low in severe asthma. Eur. Respir. J. 2005; 26: 257-264.
53. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Garg M.L. Airway and circulating levels of carotenoids in asthma and healthy controls. J. Am. Coll. Nutr. 2005; 24: 448-455.
54. Bodner C., Godden D., Brown K., Little J., Ross S., Seaton A. Antioxidant intake and adult-onset wheeze: a case-control study. Eur. J. Respir. 1999; 13: 22-30.
55. Britton J.R., Pavord J.D., Richards K.A. Dietary antioxidant vitamin intake and lung function in the general population. Am. J. Respir. Crit. Care Med. 1995; 151: 1383-1387.
56. Romieu I., Sienra-Monge J.J., Ramirez-Aguilar M. Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am. J. Respir. Crit. Care Med. 2002; 166: 703-709.
57. Talati M., Meyrick B., Peebles R.S. i wsp. Oxidant stress modulates murine allergic airway response. Free Radic. Biol. Med. 2006: 40: 1210-1219.
58. Gvozdjakova A., Kucharska J., Bartkovjakova M., Gazdikova K., Gazdik F.E. Coenzyme Q10 supplementation reduces cortico-steroids dosage in patients with bronchial asthma. Biofactors 2005; 25: 235-240.
59. Kruzel M.L., Bacsi A., Choudhury B., Sur S., Boldogh J. Lacto-ferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 2006 (Medline).
60. Assa'ad A.H., Ballard E.T., Sebastian K.D., Loven D.P., Boivin G.P., Lierl M.B. Effect of superoxide dismutase on a rabbit model of chronic allergic asthma. Ann. Allergy Asthma Immunol. 1998; 80: 215-224.
61. Masini E., Bani D., Vannacci A. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic. Biol., Med. 2005; 39: 520-531.